| Title | Author(s) | Year | View Count |
 | Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials | Wilschanski, M; Dupuis, A; Ellis, L; Jarvi, K; Zielenski, J; Tullis, E; Martin, S; Corey, M; Tsui, LC; Durie, P | 2006 | 1,400 |
 | The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis | Bishop, MD; Freedman, SD; Zielenski, J; Ahmed, N; Dupuis, A; Martin, S; Ellis, L; Shea, J; Hopper, I; Corey, M; Kortan, P; Haber, G; Ross, C; Tzountzouris, J; Steele, L; Ray, PN; Tsui, LC; Durie, PR | 2005 | 833 |
 | Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas | Ahmed, N; Corey, M; Forstner, G; Zielenski, J; Tsui, LC; Ellis, L; Tullis, E; Durie, P | 2003 | 343 |
| CFTR gene mutations and the pancreatic phenotype | Durie, PR; Ahmed, N; Corey, M; Zielenski, J; Ellis, L; Tullis, E; Tsui, LC | 1999 | 115 |
| Genotype/phenotype in relation to lung disease | Durie, PR; Tullis, E; Corey, M; Ellis, L; Martin, S; Jarvi, K; Zielenski, J; Gilljam, M; Tsui, LC | 1998 | 90 |
| Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements | Wilson, DC; Ellis, L; Zielenski, J; Corey, M; Ip, WF; Tsui, LC; Tullis, E; Knowles, MR; Durie, PR | 1998 | 298 |
|
